Germline mutations in LIAS, LIPT2 and LIPT1 result in impaired PDHc and OGDHc activity13,27,42,43, but ABHD11 loss did not significantly alter DLAT lipoylation in several cancer lines. Here, LIPT2 is linked to cancer.